IRIS UniCatt

Gagliardini, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.107
EU - Europa 1.036
AS - Asia 632
SA - Sud America 124
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 2.925
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.073
SG - Singapore 308
DE - Germania 226
PL - Polonia 209
FR - Francia 167
SE - Svezia 149
CN - Cina 138
IT - Italia 104
BR - Brasile 102
VN - Vietnam 56
UA - Ucraina 47
GB - Regno Unito 43
IN - India 39
IE - Irlanda 30
ID - Indonesia 19
FI - Finlandia 17
CA - Canada 16
RU - Federazione Russa 15
BD - Bangladesh 12
HK - Hong Kong 12
AR - Argentina 11
JP - Giappone 11
TR - Turchia 11
MX - Messico 10
NL - Olanda 7
ZA - Sudafrica 7
IR - Iran 5
JM - Giamaica 5
BE - Belgio 4
SA - Arabia Saudita 4
TN - Tunisia 4
CL - Cile 3
LT - Lituania 3
MA - Marocco 3
AT - Austria 2
AU - Australia 2
DK - Danimarca 2
EC - Ecuador 2
EG - Egitto 2
ES - Italia 2
EU - Europa 2
IQ - Iraq 2
KE - Kenya 2
PA - Panama 2
PH - Filippine 2
VE - Venezuela 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BO - Bolivia 1
CG - Congo 1
CH - Svizzera 1
CO - Colombia 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
GR - Grecia 1
HR - Croazia 1
IL - Israele 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MM - Myanmar 1
MT - Malta 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 2.925
Salva come PNG Salva come JPEG
Città #
Kraków 199
Chandler 183
Singapore 154
Ashburn 81
San Jose 66
New York 52
Jacksonville 51
Beijing 30
Dublin 30
Redmond 30
San Mateo 29
Los Angeles 27
Milan 27
The Dalles 26
Houston 24
Ann Arbor 20
Ho Chi Minh City 20
Lauterbourg 20
Jakarta 19
Dallas 18
Nanjing 18
Boston 17
Dearborn 17
Hanoi 15
Wilmington 15
Nürnberg 14
Cattolica 13
Lawrence 12
Rome 12
Changsha 11
Frankfurt am Main 11
Hong Kong 11
Lancaster 11
Woodbridge 10
Nanchang 9
Tokyo 9
Buffalo 8
Fairfield 8
Roubaix 8
Santa Clara 8
Seattle 8
Izmir 7
Montreal 7
Redwood City 7
São Paulo 7
Warsaw 7
Atlanta 6
Kunming 6
Munich 6
Paris 6
Princeton 6
Pune 6
Bexley 5
Johannesburg 5
Marseille 5
Orem 5
Shenyang 5
Toronto 5
Verona 5
Washington 5
Amsterdam 4
Augusta 4
Brooklyn 4
Brussels 4
Chennai 4
Falls Church 4
Hangzhou 4
Hebei 4
Manchester 4
Mexico City 4
Stockholm 4
Anápolis 3
Biên Hòa 3
Boardman 3
Cambridge 3
Clearwater 3
Des Moines 3
Guangzhou 3
Helsinki 3
Jinan 3
Kingston 3
Leawood 3
London 3
Phoenix 3
Portsmouth 3
San Francisco 3
Turin 3
University Park 3
Andover 2
Ankara 2
Araçatuba 2
Bari 2
Brasília 2
Bremen 2
Calgary 2
Council Bluffs 2
Cupertino 2
Córdoba 2
Da Nang 2
Dhaka 2
Totale 1.581
Salva come PNG Salva come JPEG
Nome #
Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis 226
Prevalence of osteoporosis and predictors of low BMD in a cohort of HIV-1-infected patients in Rome: features of a population at high risk 218
Liver fibrosis is associated with cognitive impairment in HIV-positive patients 218
Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre 217
Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE) 201
Safety and therapeutic efficacy of the switch to maraviroc+darunavir/ritonavir in HIV/HCV coinfected patients: initial results from GUSTA study 190
Ophthalmic artery resistance index IS increased in HIV-Infected patients and is influenced by protease inhibitors exposure 186
Efficacy and safety of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study 183
Lipid-lowering effect and changes in estimated cardiovascular risk after switching to a tenofovir-containing regimen for the treatment of HIV-infected patients 166
Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy 154
Bone mineral density improvement after 48 weeks of switch to maraviroc+darunavir/ritonavir 300/800/100 mg QD, preliminary results of GUSTA study 147
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-Week results of a randomized trial 141
Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial 135
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 135
Liver fibrosis progression and clinical outcomes are intertwined: Role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCVcoinfected patients with detectable HCV-RNA A MASTER cohort study 133
Impact of the M184V Resistance Mutation on Virological Efficacy and Durability of Lamivudine-Based Dual Antiretroviral Regimens as Maintenance Therapy in Individuals With Suppressed HIV-1 RNA: A Cohort Study 115
3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir 109
Two Distinct Hepatitis C Virus Genotype 1a Clades Have Different Geographical Distribution and Association With Natural Resistance to NS3 Protease Inhibitors 83
Totale 2.957
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.610
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.610
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 0 0 0 0 0 0 4 17 2
2021/2022204 4 11 4 17 6 15 4 36 14 29 26 38
2022/2023426 66 69 29 68 28 55 7 50 44 1 8 1
2023/2024205 6 63 4 23 12 50 14 1 0 2 22 8
2024/2025360 3 14 21 11 40 7 8 29 73 25 70 59
2025/2026781 130 10 40 112 174 37 156 40 37 45 0 0
Totale 2.957